Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease

Table 2 Histological changes and the effect of cell treatment in the 5/6 nephrectomized animals

	CKD	RPC	hiPSC
IFTA	44.9 ± 26^a,b	15.8 ± 13.2	13.6 ± 13.1
Glomerulosclerosis	0.13 ± 0.13^c,d	0.01 ± 0.01	0.008 ± 0.01

Data are expressed as means ± SD. Abbreviation: IFTA interstitial fibrosis and tubular atrophy. ^ap = 0.003 vs. RPC; ^bp = 0.01 vs. hiPSC; ^cp = 0.01 vs. RPC; ^dp = 0.01 vs. hiPSC

ISSN: 1757-6512